<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03229811</url>
  </required_header>
  <id_info>
    <org_study_id>831500</org_study_id>
    <nct_id>NCT03229811</nct_id>
  </id_info>
  <brief_title>Integrating Conservative Kidney Management Options and Advance Care Planning Into a Pre-Dialysis Educational Program</brief_title>
  <official_title>Integrating Conservative Kidney Management Options and Advance Care Planning Into a Pre-Dialysis Educational Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goals of this work will be to evaluate the preliminary efficacy of a comprehensive
      pre-dialysis education program on increased knowledge of conservative kidney management and
      advance care planning among patients with advanced CKD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This intervention will be randomized among patients with advanced chronic kidney disease.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 30, 2020</start_date>
  <completion_date type="Anticipated">March 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Comprehensive pre-dialysis program incorporating conservative and advance care planning education</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knowledge of conservative kidney management and advance care planning</measure>
    <time_frame>Baseline and Day 1 post-intervention</time_frame>
    <description>Change in knowledge of conservative kidney management and advance care planning (mean score)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Communication of EOL preferences with healthcare providers and family members</measure>
    <time_frame>12 weeks post-intervention</time_frame>
    <description>Binary outcome (yes/no)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Completion of healthcare proxy forms, living wills, and POLST forms</measure>
    <time_frame>Day 1 post intervention and 12 weeks post-intervention</time_frame>
    <description>Binary outcome (yes/no)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Advance Care Planning</condition>
  <condition>Chronic Kidney Diseases</condition>
  <condition>Conservative Kidney Management</condition>
  <arm_group>
    <arm_group_label>Standard pre-dialysis education</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard pre-dialysis options education including hemodialysis, peritoneal dialysis, and kidney transplantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ESRD education + ACP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard ESRD education + conservative kidney management and advance care planning education</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ESRD education + conservative kidney management and ACP education</intervention_name>
    <description>Targeted conservative kidney management and advance care planning education delivered in person by trained healthcare providers</description>
    <arm_group_label>ESRD education + ACP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stage 4 or 5 CKD (defined by the CKD-EPI estimation of GFR &lt; 30 ml/min/1.73m2)

          -  Age 65 years or greater or frail

          -  self-reported Black or White race

        Exclusion Criteria:

          -  History of dementia

          -  History of legal blindness

          -  Listed for kidney transplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nwamaka Eneanya, MD, MPH</last_name>
    <phone>215-746-5080</phone>
    <email>Nwamaka.eneanya@pennmedicine.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Nwamaka Eneanya, MD, MPH</last_name>
      <phone>215-746-5080</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>July 21, 2017</study_first_submitted>
  <study_first_submitted_qc>July 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2017</study_first_posted>
  <last_update_submitted>March 31, 2020</last_update_submitted>
  <last_update_submitted_qc>March 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Nwamaka Eneanya, MD, MPH</investigator_full_name>
    <investigator_title>Attending Nephrologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

